Senior insider sale
Chief Financial Officer at RECURSION PHARMACEUTICALS, INC. — senior position signals high conviction
$686.4K
95K shares
SECORA MICHAEL plans to sell 95K shares of RECURSION PHARMACEUTICALS, INC. valued at approximately $686.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Stock Option Exercise
Cash
ESPP Purchase
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/15/2023 | Stock Option Exercise Cash | 2.25K | — |
5/22/2023 | ESPP Purchase Cash | 2.75K | — |
| Total | 5K | ||
Completed
Units to sell
15K
Market value
$98.5K
Units to sell
15K
Market value
$97.2K
Units to sell
15K
Market value
$112.2K
Units to sell
15K
Market value
$116.3K
Units to sell
15K
Market value
$114.9K
Units to sell
15K
Market value
$114.6K
Planned — Approximate Date
Units to sell
5K
Market value
$32.6K
Units
95K
Value
$686.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/15/2025 | 15K | $98.5K | — | Completed |
1/14/2025 | 15K | $97.2K | — | Completed |
12/11/2024 | 15K | $112.2K | — | Completed |
12/10/2024 | 15K | $116.3K | — | Completed |
11/13/2024 | 15K | $114.9K | — | Completed |
11/12/2024 | 15K | $114.6K | — | Completed |
| Planned — Approximate Date | ||||
1/17/2025 | 5K | $32.6K | NASDAQ | Planned |
| Total | 95K | $686.4K | ||